Treatment of oligodendroglioma: An update

Neuro-Oncology

Volumn 1, Issue 1, 1999, Pages 61-68

  Paleologos, Nina A ^a,c   Cairncross, J Gregory ^b  

^a EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c Division of Neurology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ALLELE; BRAIN TUMOR; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PATHOLOGY; REVIEW; SURVIVAL;

ADULT; ALLELES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTICENTER STUDIES; OLIGODENDROGLIOMA; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032601139     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/15228517-1-1-61     Document Type: Article

References (61)

1. Bailey, P., and Bucy, P.C. (1929) Oligodendrogliomas of the brain. J. Pathol. 32, 735-751.
2. Bailey, P., and Cushing, H. (1926) Tumors of the Glioma Group. Philadelphia: Lippincott.
3. Bailey, P., and Hiller, G. (1924) The interstitial tissues of central nervous system: A review. J. Nerv. Ment. Dis. 337-361.
4. Brown, M.T., Cairncross, J.G., Vick, N.A., Mcdonald, D.R., Friedman, H.S., Dropcho, E.J., Schold, S.C., Jr.(1990) Differential response of recurrent oligodendrogliomas vs astrocytomas to intravenous (iv) melphalan. Neurology 40 (Suppl. 1), 397-398. (Abstract)
5. Bullard, D.E., Rawlings, C.E., III, Phillips, B., Cox, E.B., Schold, S.C., Jr., Burger, P., and Halperin, E.C. (1987) Oligodendroglioma: An analysis of the value of radiation therapy. Cancer 60, 2179-2188.
6. Cairncross, J.G., and Eisenhauer, E.A. (1995) Response and control: Lessons from oligodendroglioma. J. Clin. Oncol. 13, 2475-2476. (Letter)
7. Cairncross, J.G., and Macdonald, D.R. (1988) Successful chemotherapy for recurrent malignant oligodendroglioma. Ann. Neurol. 23, 360-364.
8. Cairncross, G., MacDonald, D., Ludwin, S., Lee, D., Cascino, T., Buckner, J., Fulton, D., Dropcho, E., Stewart, D., and Schold, C., Jr. (1994) Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J. Clin. Oncol. 12, 2013-2021.
9. Cairncross, G., Swinnen, L., Stiff, P., Rosenfeld, S., Vaughan, W., Paleologos, N., Kaminer, L., DeAngelis, L., Nimer, S., Dropcho, E., Peterson, K., Forsyth, P., Stewart, D., Weaver, S., Lieberman, F., Macdonald, D., Ramsay, D., Smith, A. (1997) High-dose thiotepa with hematopoietic reconstitution (deferring radiation) for newly diagnosed aggressive oligodendroglioma. ASCO 16, 388a. (Abstract)
10. Cairncross, J.G., Ueki, K., Zlatesou, M.C., Lisle, D.K., Finkelstein, D.M., Hammond, R.R., Silver, J.S., Stark, P.C., Macdonald, D.R., Ino, Y., Ramsay, D.A., and Louis, D.N. (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J. Natl. Cancer Inst. 90, 1473-1479.
11. Celli, P., Nofrone, I., Palma, L., Cantore, G., and Fortuna, A. (1994) Cerebral oligodendroglioma: Prognostic factors and life history. Neurosurgery 35, 1018-1035.
12. Chen, R., Macdonald, D.R., and Ramsay, D.A. (1995) Primary diffuse leptomeningeal oligodendroglioma. Case report. J. Neurosurgery 83, 724-728.
13. Dolinskas, C.A., and Simeone, F.A. (1987) CT characteristics of intraventricular oligodendrogliomas. Am. J. Neuroradiol. 8, 1077-1082.
14. Fortuna, A., Celli, P., and Palma, L. (1980) Oligodendroglioma of the spinal cord. Acta. Neurochir. 52, 305-329.
15. 6-alkylguanine-DNA alkyltransferase activity in human brain tumors. Cancer Lett. 55, 153-158.
16. Gannett, D.E., Wisbeck, W.M., Silbergeld, D.L., and Berger, M.S. (1994) The role of postoperative irradiation in the treatment of oligodendroglioma. Int. J. Radiat. Oncol. Biol. Physics 30, 567-573.
17. Garza-Mercado, R., Campa, H., and Grajeda, J. (1987) Primary oligodendroglioma of the septum pellucidum. Neurosurgery 21, 78-80.
18. Glass, J., Hochberg, F.H., Gruber, M.L., Louis, D.N., Smith, D., and Rattner, B. (1992) The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. J. Neurosurg. 76, 741-745.
19. Kallio, M. (1990) Therapy and survival of adult patients with intracranial glioma in a defined population. Acta. Neurol. Scand. 81, 541-549.
20. Kedar, A., Maria, B.L., Graham-Pole, J., Ringdahl, D.M., Quislng, R.G., Mickle, J.P., Mendenhall, N.P., Marcus, R.B., Jr., and Gross, S. (1994) High-dose chemotherapy with marrow reinfusion and hyperfractionated irradiation for children with high-risk brain tumors. Med. Pediatr. Oncol. 23, 428-436.
21. Kros, J.M., Lie, S-T., and Stefanko, S.Z. (1994a) Familial occurrence of polymorphous oligodendroglioma. Neurosurgery 34, 732-736.
22. Kros, J.M., Pieterman, H., Van Eden, C.G., and Avezaat, C.J. (1994b) Oligodendroglioma: The Rotterdam-Dijkzigt experience. Neurosurgery 34, 959-966.
23. Kyritsis, A.P., Yung, W.K.A., Bruner, J., Gleason, M.J., and Levin, V.A. (1993) The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 32, 365-371.
24. Lee, S.K., and Kelly, D.L., Jr. (1990) Primary oligodendroglioma of the lateral ventricle. South. Med. J. 83, 254-255.
25. Lee, Y-Y., and Tassel, P. (1989) Intracranial oligodendrogliomas: Imaging findings in 35 untreated cases. Am. J. Roentgenol. 152, 361-369.
26. Leighton, C., Fisher, B., Bauman, G., Depiero, S., Stitt, L., MacDonald, D., and Cairncross, G. (1997) Supratentorial low-grade glioma in adults: An analysis of prognostic factors and timing of radiation. J. Clin. Oncol. 15, 1294-1301.
27. Levin, V.A., Edwards, M.S., Wright, D.C., Seager, M.L., Schimberg, T.P., Townsend, J.J., and Wilson, C.B. (1980) Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat. Rep. 64, 237-244.
28. Lindegaard, K-F., Mork, S.J., Eide, G.E., Halvorsen, T.B., Hatlevoll, R., Solgaard, T., Dahl, O., and Ganz, J. (1987) Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma. J. Neurosurg. 67, 224-230.
29. Ludwig, C.L., Smith, M.T., Godfrey, A.D., and Armbrustmacher, V.W. (1986) A clinicopathological study of 323 patients with oligodendrogliomas. Ann. Neurol. 19, 15-21.
30. Macdonald, D.R., O'Brien, R.A., Gilbert, J.J., and Cairncross, J.G. (1989) Metastatic anaplastic oligodendroglioma. Neurology 39, 1593-1596.
31. Macdonald, D.R., Gaspar, L.E., and Cairncross, J.G. (1990) Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann. Neurol. 27, 573-574.
32. Maintz, D., Fiedler, K., Koopmann, J., Rollbrocker, B., Nechev, S., Lenartz, D., Stangl, A.P., Louis, D.N., Schramm, J., Wiestler, O.D., and von Deimling, A. (1997) Molecular genetic evidence for subtypes of oligoastrocytomas. J. Neuropathol. Exp. Neurol. 56, 1098-1104.
33. Margain, D., Peretti-Viton, P., Perez-Castillo, A.M., Martini, P., and Salamon, G. (1991) Oligodendrogliomas. J. Neuroradiol. 18, 153-160.
34. Mason, W.P., Krol, G.S., and DeAngelis, L.M. (1996) Low-grade oligodendroglioma responds to chemotherapy. Neurology 46, 203-207.
35. Mørk, S.J., Lindegaard, K.-F., Halvorsen, T.B., Lehmann, E.H., Solgaard, T., Hatlevoll, R., Harvei, S., and Ganz, J. (1985) Oligodendroglioma: Incidence and biological behavior in a defined population. J. Neurosurg. 63, 881-889.
36. Nijjar, T.S., Simpson, W.J., Gadalla, T., and McCartney, M. (1993) Oligodendroglioma: The Princess Margaret Hospital experience (1958-1984). Cancer 71, 4002-4006.
37. 6-methyguanine-DNA methyltransferase in tumors and cells of the oligodendrocyte lineage. Can. J. Neurol. Sci. 22, 111-115.
38. Pagni, C.A., Canavero, S., and Gaidolfi, E. (1991) Intramedullary "holocord" oligodendroglioma: Case report. Acta. Neurochir. 113, 96-99.
39. Paleologos, N.A., Zemrus, T., Allen, C.V., Ragin, A., Walsh, A., Lapin, G.D., Groothuis, D.R., and Vick, N.A. (1992) Oligodendrogliomas: CT measurement of transcapillary permeability and response to vincristine chemotherapy. Ann. Neuro. 23, 289. (Abstract)
40. Paleologos, N., MacDonlad, D., and Vick, N. (1995) Neoadjuvant (pre-radiation [RT]) procarbazine, CCNU and vincristine (PCV) for anaplastic oligodendroglioma (AO) and aggressive oligodendroglioma (AgO). Neurology 45 (Suppl. 4), A387. (Abstract)
41. Paleologos, N.A., Vick, N.A., and Kachoris, J.P. (1994) Chemotherapy for low-grade oligodendrogliomas? Ann. Neurol. 36, 294-295. (Abstract)
42. Peterson, K., Paleologos, N., Forsyth, P., Macdonald, D.R., and Cairncross, J.G. (1996) Salvage chemotherapy for oligodendroglioma. J. Neurosurg. 85, 597-601.
43. Reedy, D.P., Bay, J.W., and Hahn, J.F. (1983) Role of radiation therapy in the treatment of cerebral oligodendroglioma: An analysis of 57 cases and a literature review. Neurosurgery 13, 499-503.
44. Reifenberger, J., Reifenberger, G., Liu, L., James, C.D., Wechsler, W., and Collins, V.P.S (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am. J. Pathol. 145, 1175-1190.
45. Roosen, N., De La Porte, C., Van Vyve, M., Solheid, C., and Selosse, P. (1984) Familial oligodendroglioma: Case report. J. Neurosurg. 60, 848-849.
46. Roelvink, N.C.A., Kamphorst, W., Lindhout, D., and Ponssen, H. (1986) Concordant cerebral oligodendroglioma in identical twins J. Neurol. Neurosurg. Psychiatry 49, 706-708.
47. Rogers, L.R., Estes, M.L., Rosenbloom, S.A., and Harrold, L. (1995) Primary leptomeningeal oligodendroglioma: Case report. Neurosurgery 36, 166-169.
48. Russell, D.S., and Rubinstein, J.J. (1989) Pathology of Tumors of the Nervous System. Fifth edition. Baltimore: Williams and Wilkins.
49. Saarinen, U.M., Pihko, H., and Makipernaa, A. (1990) High-dose thiotepa with autologous bone marrow rescue in recurrent malignant oligodendroglioma: A case report. J. Neurooncol. 9, 57-61.
50. Shaw, E.G., Scheithauer, B.W., O'Fallon, J.R., Tazelaar, H.D., and Davis, D.H. (1992) Oligodendrogliomas: The Mayo Clinic experience. J. Neurosurg. 76, 428-434.
51. Shaw, E.G., Scheithauer, B.W., O'Fallon, J.R., and Davis, D.H. (1994) Mixed oligoastrocytomas: A survival and prognostic factor analysis. Neurosurgery 34, 577-582.
52. Shimizu, K.T., Tran, L.M., Mark, R.J., and Selch, M.T. (1993) Management of oligodendrogliomas. Radiology 186, 569-572.
53. Smith, M.T., Ludwig, C.L., Godfrey, A.D., and Armbrustmacher, V.W. (1983) Grading of oligodendrogliomas. Cancer 52, 2107-2114.
54. Soffietti, R., Chio, A., Mocellini, C., Rudà, R., Vigliani, M.C., Schiffer, D., Sciolla, R., Seliak, D. (1994) Response of oligodendroglial tumors to PCV chemotherapy. Neurology 44 (Suppl. 2), A309-A310. (Abstract)
55. Soffietti, R., Chio, A., Mocellini, C., Rudà, R., Schiffer, D., Sciolla, R. (1995) Treatment with carboptatinum of oligodendroglial tumors recurrent after PCV chemotherapy. Neurology 45 (Suppl. 4), A261. (Abstract)
56. Sun, Z.M., Genka, S., Shitara, N., Akanuma, A., and Takakura, K. (1988) Factors possibly influencing the prognosis of oligodendroglioma. Neurosurgery 22, 886-891.
57. Vonofakos, D., Marcu, H., and Hacker, H. (1979) Oligodendrogliomas: CT patterns with emphasis on features indicating malignancy. J. Comp. Assist. Tomogr. 3, 783-788.
58. Wallner, K.E., Gonzales, M., and Sheline, G.E. (1988) Treatment of oligodendrogliomas with or without postoperative irradiation. J. Neurosurg. 68, 684-688.
59. 6-alkylguanine-DNA alkyltransferase activity in human brain and brain tumors. Carcinogenesis 5, 121-124.
60. Wilkinson, I.M.S., Anderson, J.R., and Holmes, A.E. (1987) Oligodendroglioma: An analysis of 42 cases. J. Neurol. Neurosurg. Psychiatry 50, 304-312.
61. Yuen, S.T., Fung, C.F., Ng, T.H., and Leung, S.Y. (1992) Central neurocytoma: its differentiation from intraventricular oligodendroglioma . Childs Nerv. Syst. 8, 383-388.